Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
2
×
drugs
fda
2
×
indiana blog main
indiana top stories
2
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alder biopharmaceutical
allergan
american academy of neurology
amgen
antibiotics
arvinas
astrazeneca
atogepant
biohaven
bob azelby
What
make
2
×
approval
arguments
big
biotechs
chose
class
close
commercialized
companies
company
competitors
decades
device
drug
drugs
fda
firms
ipo
ipos
life
medical
meeting
migraine
neuro
new
open
oral
potential
q
quarter
science
therapies
way
week
window
won
year
Language
Current search:
make
×
fda
×
" indiana top stories "
×
" detroit top stories "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way